Morphosys Ag (MOR) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Novartis BidCo Germany AG plans to merge with MorphoSys AG, aiming for a merger squeeze-out to acquire the shares of MorphoSys’s minority shareholders. Novartis, already holding 91.04% of MorphoSys’s share capital, proposes negotiations for a merger agreement, with the intent to offer cash compensation yet to be determined. The proposed squeeze-out will be subject to the approval of MorphoSys AG shareholders at the upcoming Annual General Meeting in August 2024.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.